Application deadline for new drug, gene and biomarker discovery pilot and feasibility program is May 14

The Vanderbilt DRTC facilitates the discovery, application and translation of scientific knowledge to improve the care of patients with diabetes.

The Vanderbilt Diabetes Research and Training Center  announces a new pilot and feasibility program (P&F) for innovative studies that use the VICB High-Throughput Screening Facility, BioVU or the Mass Spectrometry Research Center for research on diabetes, obesity and metabolism.

The application deadline is 9 a.m. on May 14. Application forms and detailed instructions can be obtained from the DRTC P&F website.

Contact: Deborah Caplenor Brown